Literature DB >> 2273206

Interaction of glucose and pyridostigmine on the secretion of growth hormone (GH) induced by GH-releasing hormone (GHRH).

G Delitala1, P A Tomasi, M Palermo, P Fresu.   

Abstract

In order to investigate the mechanisms by which hyperglycaemia induces an inhibition of GHRH-induced GH release, we gave the following treatments to seven normal men: a) GHRH 100 micrograms iv; b) pyridostigmine (PD) 120 mg po 60 min before GHRH; c) glucose 250 mg/kg iv as a bolus (10 min before GHRH) plus 10 mg/kg/min until the end of the test; d) glucose pyridostigmine and GHRH as above. Glucose significantly reduced GHRH-stimulated GH levels, whereas PD significantly enhanced them. When PD and glucose were given together, the effect on GHRH-stimulated GH secretion was not different from the algebraic sum of the single effects of the two substances. Thus glucose seems to be able to exert its inhibition, at least partially, also when pyridostigmine is coadministered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273206     DOI: 10.1007/BF03349588

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Potentiation of cholinergic tone counteracts the suppressive effect of oral glucose administration on the GH response to GHRH in man.

Authors:  S Balzano; S Loche; M L Murtas; T Fanni; V Sica; C Pintor; E Martino
Journal:  Horm Metab Res       Date:  1989-01       Impact factor: 2.936

2.  Plasma insulin and growth hormone during 22-hour fasts and after graded glucose loads in six healthy adults.

Authors:  W M Hunter; J M Willoughby; J A Strong
Journal:  J Endocrinol       Date:  1968-03       Impact factor: 4.286

Review 3.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

4.  Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man.

Authors:  F Massara; E Ghigo; P Molinatti; E Mazza; V Locatelli; E E Müller; F Camanni
Journal:  Acta Endocrinol (Copenh)       Date:  1986-09

5.  Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?

Authors:  A Peñalva; B Burguera; X Casabiell; J A Tresguerres; C Dieguez; F F Casanueva
Journal:  Neuroendocrinology       Date:  1989-05       Impact factor: 4.914

6.  Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression.

Authors:  M Press; W V Tamborlane; M O Thorner; W Vale; J Rivier; J M Gertner; R S Sherwin
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

7.  Glucose modulation of somatostatin and LHRH release from rat hypothalamic fragments in vitro.

Authors:  A M Lengyel; A Grossman; A C Nieuwenhuyzen-Kruseman; J Ackland; L H Rees; M Besser
Journal:  Neuroendocrinology       Date:  1984-07       Impact factor: 4.914

8.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man.

Authors:  A Masuda; T Shibasaki; M Nakahara; T Imaki; Y Kiyosawa; K Jibiki; H Demura; K Shizume; N Ling
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.